Continue MDT, start systemic steroids
The patient is experiencing a Type 1 lepra reaction (reversal reaction), which occurs during leprosy treatment. Management involves continuing MDT (do not stop anti-leprosy treatment) and adding systemic corticosteroids to reduce inflammation and prevent nerve damage. Stopping MDT would lead to disease progression.